Allogeneic stem cell transplantation in non-Hodgkin lymphoma: Benefit remains unclear

by Institute for Quality and Efficiency in Health CareCancer cell during cell division. Credit: National Institutes of HealthThe German Institute for Quality and Efficiency in Health Care (IQWiG)

Updated on: May 11,2024

Allogeneic stem cell transplantation in non-Hodgkin lymphoma: Benefit remains unclear

by Institute for Quality and Efficiency in Health CareCancer cell during cell division. Credit: National Institutes of HealthThe German Institute for Quality and Efficiency in Health Care (IQWiG)

Updated on:May 11,2024

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research

Updated on: January 15,2024

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research

Updated on:January 15,2024

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on: April 07,2024

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on:April 07,2024

Study results may lead to improved diagnostics for breast cancer

by WileyThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Ka

Updated on: July 02,2024

Study results may lead to improved diagnostics for breast cancer

by WileyThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Ka

Updated on:July 02,2024

Researchers find BRAF protein modification could slow tumor growth

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0The protei

Updated on: June 24,2024

Researchers find BRAF protein modification could slow tumor growth

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0The protei

Updated on:June 24,2024

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on: February 23,2024

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on:February 23,2024

Novel bioassay predicts cancer patients' response to immunotherapy

byBen-Gurion University of the NegevIcAR response to fresh and fixed PDXs and generation of an IcAR score.(A) Schematic representation of the IcAR assay protocol. Following flow cytometry determ

Updated on: January 12,2024

Novel bioassay predicts cancer patients' response to immunotherapy

byBen-Gurion University of the NegevIcAR response to fresh and fixed PDXs and generation of an IcAR score.(A) Schematic representation of the IcAR assay protocol. Following flow cytometry determ

Updated on:January 12,2024

New promising targeted drug for a rare leukemia

by University of HelsinkiBCL-2 family gene expression in blasts across AML types at single cell resolution. (A) UMAP plot of scRNA-seq data of blasts from AML with megakaryoblastic differentiatio

Updated on: February 18,2024

New promising targeted drug for a rare leukemia

by University of HelsinkiBCL-2 family gene expression in blasts across AML types at single cell resolution. (A) UMAP plot of scRNA-seq data of blasts from AML with megakaryoblastic differentiatio

Updated on:February 18,2024

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Updated on: January 02,2024

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Updated on:January 02,2024

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

Updated on: February 03,2024

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

Updated on:February 03,2024

Drug hobbles deadly liver cancer by stifling protein production

by University of California, San FranciscoCredit: CC0 Public DomainIn laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a su

Updated on: May 25,2024

Drug hobbles deadly liver cancer by stifling protein production

by University of California, San FranciscoCredit: CC0 Public DomainIn laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a su

Updated on:May 25,2024

Researchers identify a new biomarker for personalised treatments against cancer

by Institute for Research in Biomedicine (IRB Barcelona)Different localization of the proteins involved in apoptosis in basal (Ctrl) and upon death receptor induction with TRAIL. Credit: Saška Iv

Updated on: June 19,2024

Researchers identify a new biomarker for personalised treatments against cancer

by Institute for Research in Biomedicine (IRB Barcelona)Different localization of the proteins involved in apoptosis in basal (Ctrl) and upon death receptor induction with TRAIL. Credit: Saška Iv

Updated on:June 19,2024